Bivalent Vaccine for HPV: Interim Phases III Data Show High Efficacy
Jorma Paavonen
REFERENCE: Lancet 369:2161-2170, 2007
JORMA PAAVONEN, University of Helsinki
High efficacy of the bivalent vaccine for human papillomavirus is reported in the Lancet by an international group headed by Jorma Paavonen from Helsinki. Nicola Solomon asked him about
JORMA PAAVONEN, University of Helsinki
High efficacy of the bivalent vaccine for human papillomavirus is reported in the Lancet by an international group headed by Jorma Paavonen from Helsinki. Nicola Solomon asked him about